Volcano completes first human trial with OCT imaging catheter
Dutch researchers have completed the first human procedure using the Volcano Optical Coherence Tomography (OCT) imaging catheter.
Patrick Serruys, MD, at the Thoraxcenter, in Rotterdam, Netherlands, performed the procedure. Volcano said its OCT imaging catheter will complement its existing line of IVUS imaging catheters and pressure guidewires used for coronary imaging and lesion assessment.
Volcano acquired its OCT technology through the CardioSpectra acquisition in December 2007.
Volcano said its OCT imaging platform provides high-resolution images in the 10-15 micron range. “We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs,” said Michel Lussier, president of Volcano Europe.
Patrick Serruys, MD, at the Thoraxcenter, in Rotterdam, Netherlands, performed the procedure. Volcano said its OCT imaging catheter will complement its existing line of IVUS imaging catheters and pressure guidewires used for coronary imaging and lesion assessment.
Volcano acquired its OCT technology through the CardioSpectra acquisition in December 2007.
Volcano said its OCT imaging platform provides high-resolution images in the 10-15 micron range. “We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs,” said Michel Lussier, president of Volcano Europe.